報價延遲最少15分鐘:2026/06/21 10:32 EDT
常規時段
|
|
|
|
|
||||||||||||
|
|
|
|
|
1.71 
|
|
|
| 價值評估 |
|
盈利(現時/預測)
-1.10/-1.21
|
|
企業價值
106.28M
|
| 資產負債 |
|
每股賬面淨值
0.41
|
| 現金流量 |
|
現金流量率
--
|
| 損益表 |
|
收益
33.59M
|
|
每股收益
0.41
|
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
同行比較之報價最少15分鐘延遲 (夜盤時段除外)
|
業務概覽
|
|||
| Rapid Micro Biosystems Inc is a life sciences technology company. Its technology uses a sensitive camera and the natural autofluorescence of living cells to identify and quantify microbial growth faster and more accurately than the traditional method, which relies on the human eye. The company develops, manufactures, markets, and sells Growth Direct systems (Systems), proprietary consumables, laboratory information management system (LIMS) connection, and other software and services to address rapid microbial analysis used for quality control in the manufacture of pharmaceuticals, medical devices, and personal care products. Geographically, it generates maximum revenue from the United States, and the rest fromSwitzerland, Germany, Japan, and all other countries. |
